A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
一项针对携带 V600BRAF 突变的晚期黑色素瘤患者的维莫非尼联合考比替尼联合聚乙二醇干扰素 (VEMUPLINT) 单中心 I 期研究
期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-020-02680-7
Ester Simeone, Giosuè Scognamiglio, Mariaelena Capone, Diana Giannarelli, Antonio M Grimaldi, Domenico Mallardo, Gabriele Madonna, Marcello Curvietto, Assunta Esposito, Fabio Sandomenico, Francesco Sabbatino, Nicholas L Bayless, Sarah Warren, SuFey Ong, Gerardo Botti, Keith T Flaherty, Soldano Ferro